
This special episode of “Oncology Peer Review On-The-Go” includes a discussion on relapsed/refractory follicular lymphoma with Javier Munoz, MD, MS, FACP.
Your AI-Trained Oncology Knowledge Connection!
This special episode of “Oncology Peer Review On-The-Go” includes a discussion on relapsed/refractory follicular lymphoma with Javier Munoz, MD, MS, FACP.
Javier L. Munoz, MD, MS, FACP, discusses how the sequencing of therapies has changed in the last year.
An expert in relapsed/refractory follicular lymphoma discusses the approval of tazemetostat as a treatment and reviews the phase 2 clinical trial data.
Javier L. Munoz, MD, MS, FACP, describes the current third-line treatment options available for relapsed/refractory follicular lymphoma.
A specialist explains the factors considered when it comes to choosing treatments for patients with relapsed/refractory follicular lymphoma, and the clinical endpoints to look for.
Javier L. Munoz, MD, MS, FACP, describes the effects of R/R FL and discusses the current treatment options available.
Published: August 29th 2021 | Updated:
Published: July 20th 2021 | Updated:
Published: July 13th 2021 | Updated:
Published: July 13th 2021 | Updated:
Published: July 6th 2021 | Updated:
Published: July 6th 2021 | Updated: